| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |